Donate

Donate

June 28, 2000

Regulation of Over the Counter Drugs Day 1

Health experts and industry lobbyists debated the extent to which prescription drugs should be converted to “over the counter” status. They … read more

Health experts and industry lobbyists debated the extent to which prescription drugs should be converted to “over the counter” status. They also talked about the sometimes blurry line between cosmetics and drugs. This program contains several short breaks. close

Report Video Issue

People in this video

Amy Alhna Program Director National Women's Health Network
Eva Bachrach Senior Vice President Consumer Healthcare Products Association

Russell Bantham Deputy Counsel Pharmaceutical Research and Manufacturers of America
Anthony Barrueta Counsel Kaiser Permanente->Government Relations
David Bradford Professor University of Utah->School of Medicine
Schumarry Chao Representative MEDIMPACT
Rebecca Chater Representative American Pharmaceutical Association
Robert DeLap Director U.S. Food and Drug Administration->Center for Drug Evaluation and Research
Thomas Donegan Vice President Cosmetic, Toiletry and Fragrance Assn.
Gerald Dunaway President AMMSYS Research, Inc.
Steve Francesco President Francesco International
Charles Ganley Director U.S. Food and Drug Administration->Nonprescription Drugs Cmte.
Linda Golodner President National Consumers League
Michael Greene Representative American College of Obstetricians and Gynecologists
Doug Hoey Vice President National Community Pharmacists Assn.
Mary Johnson Attorney
Dr. Chris Kahlenborn Participant
Brett Kay Program Associate National Consumers League
James Leyden Professor University of Pennsylvania School of Medicine
Anna Longwell Director Becton, Dickinson, and Company->Corporate Regulatory Affairs
Michael Maves President Consumer Healthcare Products Association
Warren Pinchert II President and CEO Cholestech Corporation
Robert Pinco Attorney
William Soller Senior Vice President Consumer Healthcare Products Association
Robert Temple Associate Director U.S. Food and Drug Administration->Office of Drug Evaluation
Sandra Titus Executive Secretary Nonprescription Drugs Advisory Committee
Sidney Wolfe M.D. Co-Founder and Director Public Citizen->Health Research Group
Janet Woodcock M.D. Official U.S. Food and Drug Administration

More People

Hosting Organization

U.S. Food and Drug AdministrationU.S. Food and Drug Administration

331 Views

Program ID:: 157953-1
Category:: Public Affairs Event
Format:: Public Hearing
Location:: Washington, District of Columbia, United States
First Aired:: Jun 28, 2000 | 11:33pm EDT | C-SPAN 2

Airing Details

Jun 28, 2000 | 11:33pm EDT | C-SPAN 2

MP3 audio - Standard

Price:

$0.99

Request Download
Alert me when the download is available.
- Name
- Email
Error requesting format availability.

Your request has been submitted.
There was an error processing your purchase.

Related Video

See all on Drugs (Pharmaceuticals)

July 3, 1999
Presidential Radio Address

President Clinton discussed actions to be taken to ensure food safety. In particular, he challenged Congress to pass leg…
May 2, 2005
Pharmacists and Health Policy

Pharmacists spoke about the state of independent pharmacists and the pharmaceutical industry, health care, Medicare prog…
August 3, 2005
Consumer Advertising of Prescription Drugs

Sponsored by the Christine Mirzayan Science and Technology Policy Graduate Fellowship Program seminar series, participan…
April 12, 2006
Medicare Prescription Drug Benefit

President Bush talks to students and members of the public about the Medicare prescription drug benefit at a town hall m…

User Created Clips from This Video

June 28, 2000
Reg. of Over the Ctr. Drugs
- 2 minutes
- 26 views